Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Timeframe for Mycobacterium chelonae Spread from Foot to Intra-abdominal Lymph Nodes

Characteristics of M. chelonae Infection in Immunocompetent Hosts

  • M. chelonae primarily causes skin, bone, and soft tissue infections, with dissemination being extremely rare in immunocompetent individuals 1, 2
  • The organism typically enters through direct inoculation via trauma, surgery, or other skin-breaching events 3
  • In immunocompetent patients, infections tend to remain localized to the site of entry 2, 4

Dissemination Risk Factors

  • Disseminated M. chelonae disease is primarily observed in immunocompromised patients, particularly those with advanced HIV infection with very low CD4 counts 6, 7
  • Disseminated M. chelonae disease is also observed in immunocompromised patients with organ transplantation (especially renal transplants) 7
  • Disseminated M. chelonae disease is also observed in immunocompromised patients with hematologic malignancies 7

Timeframe for Potential Spread

  • Initial localized infection typically develops within days to weeks after inoculation 8
  • Proximal lymph node involvement (e.g., inguinal nodes from foot infection) may occur within 2-10 months if inadequately treated 3
  • Spread to distant lymph nodes like intra-abdominal nodes would be exceptionally rare and would likely take many months to years, if it occurred at all 1, 2

Clinical Presentation of Lymphatic Spread

  • Lymphadenopathy in regional nodes is a typical presentation of lymphatic spread 5
  • Abscess formation in affected nodes is a possible presentation of lymphatic spread 1

Prevention of Dissemination

  • Effective treatment typically includes surgical excision of affected tissue when possible 1, 5
  • Effective treatment typically includes combination antibiotic therapy for at least 4-6 months 1, 5
  • Antibiotics with high activity against M. chelonae include clarithromycin (100% susceptibility), tobramycin (100%), and linezolid (90%) 1, 2

Important Caveats

  • Long-term follow-up is essential to ensure complete eradication 5